Showing results (311-320 of 824) with videos related to

Sort By:
Pageof 83
Expert Review of Hematology|December 20, 2013
Future agents and treatment directions in multiple myelomaEnrique M Ocio, Constantine S Mitsiades, Robert Z Orlowski, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 20, 2012
Perifosine , an oral, anti-cancer agent and inhibitor of the Akt pathway: mechanistic actions, pharmacodynamics, pharmacokinetics, and clinical activityPaul G Richardson, Cathy Eng, Jill Kolesar, et al.
Current Opinion in Hematology|September 28, 2007
Novel therapies in myelomaPatrick J Hayden, Constantine S Mitsiades, Kenneth C Anderson, et al.
Blood|October 16, 2004
Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen speciesJeong H Kim, Stephanie C Chu, Jessica L Gramlich, et al.
Blood Advances|April 30, 2025
Predictive Value of Free Light Chain Burden in Patients with AL Amyloidosis Treated with Bortezomib-Based RegimensBrendan Saunders, Foteini Theodorakakou, Despina V Fotiou, et al.
Lancet (London, England)|June 23, 2009
Multiple myelomaMarc S Raab, Klaus Podar, Iris Breitkreutz, et al.
Autophagy|December 11, 2012
Intracellular NAD(+) depletion induces autophagic death in multiple myeloma cellsMichele Cea, Antonia Cagnetta, Franco Patrone, et al.
Pageof 83